Retro Biosciences: The Quest to Extend Human Lifespan by a Decade

Retro Biosciences, a San Francisco-based biotech startup, is making waves in the field of longevity with its ambitious goal of extending the human lifespan by a decade. Under the leadership of CEO Joe Betts-LaCroix, the company plans to launch clinical trials for drugs targeting age-related diseases such as Alzheimer’s. The startup is not alone in its quest; it joins a slew of major billionaire-backed efforts in the longevity space, including Altos Labs and Unity Biotechnology.

Retro Biosciences recently achieved a significant milestone by training a model with OpenAI to convert regular cells into stem cells. This breakthrough aligns with their mission to discover and develop a groundbreaking drug within this decade. Sam Altman, CEO of OpenAI, has been a pivotal figure in Retro Biosciences' journey, initially providing the entire $180 million seed round. He continues to show his support as the company embarks on raising a $1 billion Series A funding round.

The startup's collaborations with OpenAI are crucial in advancing its research and development capabilities. By leveraging cutting-edge technology, Retro Biosciences aims to accelerate the pace at which it can achieve its objectives. The company's focus on tackling diseases like Alzheimer's underscores its commitment to enhancing the quality of life for aging populations.

Retro Biosciences' mission resonates with other high-profile longevity initiatives. Altos Labs, launched in 2022 with $3 billion and backed by Jeff Bezos, represents another significant effort in this domain. Similarly, Unity Biotechnology, supported by both Bezos and Peter Thiel, underscores the growing interest in discovering solutions for age-related ailments.

Joe Betts-LaCroix emphasizes the need for speed in achieving the company's goals. His leadership is driving Retro Biosciences toward rapid growth, fueled by substantial funding and innovative partnerships. The company's determination to extend the healthy human lifespan reflects its dedication to pioneering advancements in healthcare and biotechnology.